Download

Download Full Text (8.2 MB)

Contents

  • Genetic testing: a new paradigm for medullary thyroid carcinoma
  • Bone marrow transplantation now available as an outpatient procedure
  • Adjuvant chemotherapy for breast cancer: 20 years of progress at M. D. Anderson

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Publication Date

1995

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Gagel, R. F. (Robert F.); Cote, Gilbert; Buzdar, Aman U.; Champlin, Richard; Thyroid cancer, medullary; Thyroid Neoplasms; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Calcitonin; Parathyroid Neoplasms; Pentagastrin; Catecholamines; caldecrin; Hypocalcemia; Proto-Oncogene Proteins; Thyroidectomy; Genetic Testing; Chemotherapy, Adjuvant; Breast Neoplasms; Neoplasm Micrometastasis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Methotrexate; Fluorouracil; Doxorubicin; Breast Neoplasms -- history; Drug-Related Side Effects and Adverse Reactions; Antiemetics; Anthracyclines; Epirubicin; Survival Rate; Surgical Procedures, Operative; Neoadjuvant Therapy; Paclitaxel; Tamoxifen; Mastectomy, Segmental; Receptors, Estrogen; Mastectomy; Bone Marrow Transplantation; Transplantation, Homologous; Transplantation, Autologous; Hematopoietic Cell Growth Factors; Ovarian Neoplasms; Lymphoma; Multiple Myeloma; Leukemia; Outpatients; Outpatient Clinic for Bone Marrow Transplantation.

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Open

OncoLog, Volume 40, Number 01 January-March 1995

Share

COinS